Inhibitor of p38 map kinase
US9447076B2 · kind B2 · utility
16Cited by
25References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 13, 2015 |
| Grant date | Sep 20, 2016 |
| Priority date | — |
| Expiry date | Feb 13, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound has the following formula:The compound is a p38 MAP kinase inhibitor. The compound and its pharmaceutically acceptable salts can be used for treatment of conditions, such as inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.